MedPath

Dequalinium

Generic Name
Dequalinium
Drug Type
Small Molecule
Chemical Formula
C30H40N4
CAS Number
6707-58-0
Unique Ingredient Identifier
E7QC7V26B8

Overview

Dequalinium is an antibacterial agent with multi-targeted actions. It also possesses antifungal, antiparasitic, antiviral, anticancer, and neuroprotective properties. It is a quaternary ammonium compound, as it consists of an amphipathic cation with two aminoquinaldinium rings at both ends of a long hydrophobic hydrocarbon chain. Due to its flexible structure, dequalinium was investigated to build drug and gene delivery systems. First used as an antiseptic and disinfectant in the 1950s, dequalinium is still found in various OTC products to treat conditions of oral infections and inflammation. It is also used in vaginal tablets to treat bacterial vaginosis.

Indication

Dequalinium is used in several OTC products to treat mouth infections and inflammation, such as tonsillitis, pharyngitis, and gingivitis. As vaginal tablets, dequalinium is indicated for the treatment of bacterial vaginosis in adult women under 55 years of age.

Associated Conditions

  • Bacterial Vaginosis (BV)
  • Gingivitis
  • Inflammation of Mouth
  • Oral Candidiasis
  • Oral Malodor (Halitosis)
  • Oral bacterial infection
  • Pharyngitis
  • Stomatitis
  • Tonsillitis
  • Oral infections
  • Throat infections
  • Throat inflammation
  • Tongue inflammation
  • Ulceration of the mouth

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
DEQUADIN MINT LOZ 0.25MG
glaxo canada inc
00110566
Lozenge - Oral
.25 MG / LOZ
12/31/1985
DEQUADIN ORAL SPRAY
02522616
Solution - Buccal
0.5 % / W/V
9/28/2022
DEQUADIN LOZENGES .25MG
glaxo canada inc
00110566
Lozenge - Oral
.25 MG / LOZ
12/31/1958
DEQUADIN
02100207
Lozenge - Oral
0.25 MG
12/30/1996
DEQUADIN ORAL PAINT .5%
glaxo canada inc
00110574
Paint - Oral
0.5 %
12/31/1958
VABLYS
02518252
Vaginal Tablet - Vaginal
10 MG
5/17/2022
DEQUADIN ORAL PAINT
02091453
Solution - Buccal
0.5 % / W/V
12/31/1995

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.